Skip to main

Therapeutic Goods (Standard for Human Cell and Tissue Products—Donor Screening Requirements) (TGO 108) Order 2021

In force
Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
F2022C00276 C0109 March 2022

Details

Title ID
F2021L01326
Collection
Legislative instrument
Series
TGO 108
Type
Principal | Compilation
Compilation Register ID
F2022C00276
Registered
10 March 2022
Effective
09 March 2022
To be repealed
01 October 2031
Repealed by

Sunsetting

Most legislative instruments will sunset 10 years after registration under Chapter 3, Part 4 of the Legislation Act 2003.

Due to sunset on
01 October 2031

Disallowance and tabling

All legislative instruments that are registered must be presented for scrutiny in each House of the Parliament and, unless an exemption applies, they may be disallowed by either House. When documents are presented to the Australian Parliament for scrutiny, they are said to have been tabled.

This title is subject to disallowance under:

House of Representatives

  • Legislative Instrument
    18 October 2021
  • Explanatory Statement
    18 October 2021
  • Replacement Explanatory Statement
    17 February 2022
  • Replacement Explanatory Statement
    29 March 2022

Senate

  • Legislative Instrument
    18 October 2021
  • Explanatory Statement
    18 October 2021
  • Replacement Explanatory Statement
    28 March 2022
  • Replacement Explanatory Statement
    28 March 2022

Disallowance motions

This legislative instrument has been subject to a Motion to Disallow